Pegaptanib sodium for neovascular age-related macular degeneration: Third-year safety results of the VEGF inhibition study in ocular neovascularisation (VISION) trial

L. J. Singerman, H. Masonson, M. Patel, A. P. Adamis, R. Buggage, E. Cunningham, M. Goldbaum, B. Katz, D. Guyer

Research output: Contribution to journal › Article › peer-review

111 Scopus citations

Fingerprint

Dive into the research topics of 'Pegaptanib sodium for neovascular age-related macular degeneration: Third-year safety results of the VEGF inhibition study in ocular neovascularisation (VISION) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences